AO wrongly allocated R&D expenses by turnover; Section 80IA deductions must consider enterprise-wide benefits &DExpenses

The HC held that the AO erred in allocating R&D expenses from the head office to individual units based on turnover for the purpose of reducing deductions under Chapter VI-A. The court found no basis to assume the products resulting from the R&D would necessarily be manufactured by those units. It rejected the presumption that only units engaged in manufacturing could benefit from the R&D, recognizing that the enterprise could exploit such benefits through licensing or assignment to third parties. Consequently, the allocation of expenses among units to recalculate deductions under Section 80IA was incorrect. The decision was in favor of the assessee.

---

---

Issues Involved:
1. Allocation of Research and Development (R&D) expenses by the Head Office among manufacturing units.
2. Correlation between R&D expenses incurred by the Head Office and the business of the manufacturing units.

Issue-Wise Detailed Analysis:

1. Allocation of Research and Development (R&D) expenses by the Head Office among manufacturing units:

The appellant, engaged in manufacturing ayurvedic medicines and ointments, operates a head office and four manufacturing units. The head office and each unit have their own R&D departments. For the assessment year 1993-1994, the appellant filed a return of income showing a total income of rupees nil, claiming deductions under sections 80-I, 80HH, and 80-IA for various units. The R&D expenses of Rs.38,70,000/- incurred by the head office were allocated by the Assessing Officer (AO) to the units based on their turnover. This allocation reduced the appellant's claim for deductions under Chapter VI-A for the units. The Commissioner of Income Tax (Appeals) and the Tribunal upheld this allocation, justifying it on the grounds that the head office's R&D expenses benefited the manufacturing units.

2. Correlation between R&D expenses incurred by the Head Office and the business of the manufacturing units:

The appellant contended that the R&D activities conducted by the head office were unrelated to the business of the manufacturing units. The R&D work involved developing new medicines and medical formulae, which were not manufactured by any of the units. The Tribunal, however, presumed that the R&D expenses incurred by the head office benefited the manufacturing units. The appellant argued that the units did not benefit from the R&D activities as they did not manufacture the new drugs developed. The Supreme Court's decision in CIT vs. Sterling Foods was cited, emphasizing the need for a direct nexus between the profits and gains and the industrial undertaking for deductions under sections 80-HH, 80-I, and 80-IA. The Bombay High Court agreed with this view, stating that expenses unrelated to an industrial undertaking cannot be deducted while computing its profits and gains.

The Madras High Court's judgment in Bush Boake Allen (India) Ltd. vs. Asst. CIT was also referenced, supporting the appellant's argument that R&D expenses should not be allocated to a unit unless they directly relate to it. The Bombay High Court concluded that the presumption of a nexus between the R&D activities and the units was unfounded. The Court held that the R&D expenses incurred by the head office, which were unrelated to the units' activities, should not be apportioned to the units.

Conclusion:

The Bombay High Court answered both questions in favor of the assessee, holding that the R&D expenses incurred by the head office, which had no direct connection or benefit to the manufacturing units, should not be allocated to the units. The appeal was allowed, with no order as to costs.

---